Siemens Digitalization & Sustainable Solutions Ensure Labs are Safe, Secure and Compliant. Life Science Solutions from Siemens: Leading the Way in Science. Learn More Today!
- Future proof your lab
Embrace big data to connect with
workers and optimize your lab.
- A green lab approach
A Green Lab balances temp, humidity
& lighting for occupants' safety.
- Future proof your lab
Suchergebnisse
Suchergebnisse:
Spark’s Gene Therapy Innovation Center. Located in West Philadelphia in the heart of University City, our 500,000-square-foot, multi-story Gene Therapy Innovation Center will serve as a Roche center of excellence for gene therapy manufacturing globally. The new space will allow cross-functional teams to come together and work side by side to ...
- We are Spark
Spark is a member of the Roche Group. Our mission. We unlock...
- Our Products
Spark Therapeutics, Inc. 3737 Market Street Philadelphia, PA...
- Our scientific platform & programs
Spark Therapeutics is developing SPK-3006, an...
- Healthcare professionals
References: Berger W, Kloeckener-Gruissem B, Neidhardt J....
- Join the Spark team
The Truths We Live By. We proudly say, “We are Spark.”...
- Contact Us
For Medical Inquiries Call: 1-866-MI-SPARK (1-866-647-7275)...
- Inherited Retinal Diseases
Inherited retinal diseases (IRDs) are a group of rare...
- Hemophilia
Hemophilia is typically inherited, meaning that it’s passed...
- We are Spark
The company is currently developing several gene therapies to target a suite of diseases, including Haemophilia A and B, and several central nervous system diseases. In December 2019, the company was acquired by Hoffmann-La Roche for $4.3 billion. [6] [7] It now continues to operate as an independent subsidiary. [8]
Spark is a member of the Roche Group. Our mission. We unlock the power of gene therapy to accelerate healthcare transformation. Our vision. A world where no life is limited by disease. Meet the Spark corporate management team. Chris Stevens. Chief Patient Supply Officer. Ron Philip. Chief Executive Officer. Gallia G. Levy, M.D., Ph.D.
Spark Therapeutics was founded in 2013 and became a Member of the Roche Group in 2019. The organisation is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies for genetic diseases, including inherited retinal disorders, haemophilia, lysosomal storage disorders and neurodegenerative diseases.
12. Dez. 2022 · PHILADELPHIA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated gene therapy company today announced updated...
Spark Therapeutics, Inc. | 87,207 followers on LinkedIn. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. | At Spark® Therapeutics, we believe in...
23. Feb. 2022 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. Founded in 2013, Spark Therapeutics is the first company in the U.S. to receive FDA approval of a gene therapy for a genetic disease.
Discover hi-tech solutions for pharma containment at ChargePoint Technology. Safeguard your pharmaceuticals with our patented powder transfer systems